By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Octapharma AG 

Seidenstraße 2

Lachen    CH-8853  Switzerland
Phone: 41-55-451-2121 Fax: 41-55-451-2110



Company News
Octapharma AG Release: Publication Of Clinical Data Demonstrating Low Immunogenicity And Excellent Efficacy Of Nuwiq In Previously Untreated Patients 8/23/2017 7:29:29 AM
Octapharma AG Symposium At ISTH Berlin Supports Progress In Lifelong Treatment Of High-Risk Patients With Von Willebrand Disease (VWD) And Haemophilia A 7/11/2017 6:52:06 AM
ISTH 2017, Berlin: Octapharma AG Presents Exciting Nuwiq Data In Previously Untreated Patients And Demonstrates Real-Life Value Of Personalised Prophylaxis For Hemophilia A 7/10/2017 7:17:12 AM
Octapharma AG Activities Prominent At The Upcoming 2017 ISTH Congress In Berlin, Germany 7/6/2017 6:57:45 AM
Octapharma AG Underlines Strong Commitment To Haemophilia A Patients With The Publication Of New Clinical Data On PK-Guided Personalized Prophylaxis According To The Nupreviq Approach With Nuwiq 5/22/2017 7:07:59 AM
Octapharma AG Publishes 2016 Annual Results Reporting Revenue Of €1.6 Billion And Operating Income Of €383 Million 3/1/2017 6:17:32 AM
Octapharma AG Presents Key Data With Nuwiq In Previously Untreated Patients From The Nuprotect Study At American Society of Hematology (ASH) Annual Meeting In San Diego, USA 12/21/2016 11:45:50 AM
Octapharma AG To Sponsor Two Symposia At The 2016 World Federation Of Hemophilia (WFH) World Congress In Orlando, USA 7/22/2016 7:51:30 AM
Zika Virus Guidance From FDA Notes Safety Of Plasma Protein Products And The Availability Of Octapharma AG’s Octaplas 3/7/2016 10:29:16 AM
Octapharma AG Selects IDBS' E-WorkBook 10 2/9/2016 8:16:52 AM